Cite
APA Citation
Makker, V., Taylor, M. H., Aghajanian, C., Oaknin, A., Mier, J., Cohn, A. L., Marin, M. R., Lorenzo, R. B., Brose, M. S., DiSimone, C., Messing, M. J., Stepan, D. E., Dutcus, C. E., Wu, J., Schmidt, E. V., Orlowski, R. J., Sachdev, P., Shumaker, R., & Herraez, A. C. (n.d.). 994OLenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC). Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100097083735.0x00001c